Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01052454 · ClinicalTrials.gov registry record · Early Phase 1
Mindfulness-Based Stress Reduction for Hot Flashes
A Early Phase 1 study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 110
- Enrollment target
NCT01052454: Completed Early Phase 1 study, sponsored by University of Massachusetts, Worcester.
NCT01052454 is a Early Phase 1 study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 110 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (108% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01052454, a Early Phase 1 study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 110 participants
- Enrollment target
Study Summary
This is a study to determine if participation in a mindfulness-based stress reduction program is feasible for women experiencing five or more hot flashes/day, and whether it affects either the frequency and/or intensity of their hot flashes, or the degree of bother they experience from them
Interventions
- BEHAVIORAL Mindfulness-based stress reduction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2005-09 |
| Phase | Early Phase 1 |
What the finished NCT01052454 record still lists
NCT01052454 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (108% higher).
The record links to 0 conditions, and to 1 intervention - of which Mindfulness-based stress reduction is the first listed.
NCT01052454 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01052454 about?
NCT01052454 is a clinical study titled "Mindfulness-Based Stress Reduction for Hot Flashes". This is a study to determine if participation in a mindfulness-based stress reduction program is feasible for women experiencing five or more hot flashes/day, and whether it affects either the frequency and/or intensity of their hot flashes, or the degree of bother they experience from them
What is the current status of trial NCT01052454?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 110 participants. The study started on 2005-09.
What interventions are being tested in trial NCT01052454?
The interventions under investigation include: Mindfulness-based stress reduction (BEHAVIORAL).
Who is sponsoring clinical trial NCT01052454?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01052454's enrollment target sits among peer trials
110 167th of 2000 higher than 1,832 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia